Author correction to: J Cancer Res Clin Oncol 144(2):321–335 https://doi.org/10.1007/s00432-017-2534-z
The authors would like to include the following changes in the published article.
In the section Results, under the subsection Depth of response, PEAK, the final sentence should read as follows ‘Median DoR was longer and the resection rate higher in patients with the greatest DpR; the number of responders was also highest in the second top DpR category (Table 3b).’
Table 3: The Group 3 range in the second half (PEAK) of this table should read ‘31–53%’.
Figure 6b: The DpR ranges for Groups 3, 4 and 5 in the key should read: ‘Group 3 (DpR 31–53%); Group 4 (DpR 54–82%); Group 5 (DpR 83–100%)’.
The original article can be found online at https://doi.org/10.1007/s00432-017-2534-z.
About this article
Cite this article
Taieb, J., Rivera, F., Siena, S. et al. Author Correction: Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials. J Cancer Res Clin Oncol 144, 795–797 (2018). https://doi.org/10.1007/s00432-018-2591-y